🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Lorenz Scheppler

ORCID: 0000-0002-7405-041X
Immunology and MicrobiologyBiochemistry, Genetics and Molecular BiologySocial SciencesMedicineEconomics, Econometrics and Finance

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Safety and immunogenicity of two heterologous HIV vaccine regimens in healthy, HIV-uninfected adults (TRAVERSE): a randomised, parallel-group, placebo-controlled, double-blind, phase 1/2a study”.

Safety and immunogenicity of two heterologous HIV vaccine regimens in healthy, HIV-uninfected adults (TRAVERSE): a randomised, parallel-group, placebo-controlled, double-blind, phase 1/2a study

The Lancet HIV(2020)10.1016/s2352-3018(20)30229-0
N/A
2.7DataRank · unranked
91 citations

Daniel J Stieh, Michal Sarnecki, Stephen R. Walsh, Georgia D. Tomaras, James G. Kublin +36 more

Mosaic HIV-1 vaccine regimen in southern African women (Imbokodo/HVTN 705/HPX2008): a randomised, double-blind, placebo-controlled, phase 2b trial

The Lancet Infectious Diseases(2024)10.1016/s1473-3099(24)00358-x
N/A
1.3DataRank · unranked
40 citations

Kathryn Mngadi, Ludo Lavreys, Steven Nijs, Peter B. Gilbert, John Hural +60 more

Safety and Immunogenicity of Ad26-Vectored HIV Vaccine With Mosaic Immunogens and a Novel Mosaic Envelope Protein in HIV-Uninfected Adults: A Phase 1/2a Study

The Journal of Infectious Diseases(2022)10.1093/infdis/jiac445
N/A
0.872DataRank · unranked
36 citations

Dan H. Barouch, Christy Comeaux, Michal Sarnecki, Kathryn E. Stephenson, Stephen R. Walsh +43 more